Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma

NCT01545726 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QAW039
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals